Reng-na Yan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
To define the features of glycemic variations in drug naïve type 2 diabetic (T2D) patients with different HbA1c values using continuous glucose monitoring (CGM), a total of 195 drug naïve T2D patients were admitted. The subjects were divided into the following groups: lower HbA1c values (≤8%), moderate HbA1c values (>8% and ≤10%), and higher HbA1c values(More)
BACKGROUND To investigate whether saxagliptin add-on therapy to continuous subcutaneous insulin infusion (CSII) further improve blood glycemic control than CSII therapy in patients with newly diagnosed type 2 diabetes (T2D). METHODS This was a single-center, randomized, control, open-labeled trial. Newly diagnosed T2D patients were recruited between(More)
  • 1